1Seifert P,Baker LH,Reed ML,et al. Comparison of continusly infused 5-fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinoma[J]. Cancer, 1975,36(1):123～128.
2Hori T,Takahashi E,Ayusawa D,et al. Regional assignment of the human thymidylate synthase(TS) gene to chromosome band 18p11.32 by non-isotopic in situ hybridization[J]. Hum Genet, 1990,85(3):576～580.
3Lenz HJ,Leichman CG,Danenberg KD,et al. Thymidylate synthase mRNA level in adenocarcinoma of the stomach:a predictor for primary tumor response and overall survival[J]. J Clin Oncol, 1996,14(1):176～182.
4Yeh KH,Shun CT,Chen CL,et al. High expression of thymidylate synthase is associated with the drug resistance of gastric carcinoma to high dose 5-fluorouracil-based systemic chemotherapy[J]. Cancer, 1998,82(9):1626～1631.
5Johnston PG,Lenz HJ,Leichman CG,et al. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors[J]. Cancer Res, 1995,55(7):1407～1412.
6Davies MM,Johnston PG,Kaur S,et al. Colorectal liver metastasis thymidylate synthase staining correlates with response to hepatic arterial floxuridine[J]. Clin Cancer Res, 1999,5(2):325～328.
7Bathe OF,Franceschi D,Livingstone AS,et al. Increased thymidylate synthasegene expression in liver metastases from colorectal carcinoma:implication for chemotherapeutic options and surviral[J]. Cancer J Sci Am, 1999,5(1):34～40.
8Leichman L,Lenz HJ,Leichman CG,et al. Quantitation of intratumoral thymidylate synthase expression predicts for resistance to protracted infusion of 5-fluorouracil and weekly leucovorin in disseminated colorectal cancers:preliminary report from an ongoing trial[J]. Eur J Cancer, 1995,31A(7,8):1306～1310.
9Leichman CG. Thymidylate synthase as a predictor of response[J]. Oncology Huntingt, 1998,12(8 Suppl 6):43～47.
10Suda Y,Uchida K,Shioya T,et al. 5-FU sensitivity and thymidylate synthase in gastric cancer[J]. Gan To Kagaku Ryoho, 1999,26(14):2169～2173.
8Smith D, Gallapher N. A phase Ⅱ/Ⅲ study comparing intravenous ZD9331 with gemcitabine in patients with pancreatic cancer[J]. Eur J Cancer, 2003,39(7) :1377 - 1383.
9Mauritz R, Peters GJ, Priest DG. Et al. Multiple mechanisms of resistence to methotrexate and novel antifolates in human CCRFCEM leukemia cells and their implications for folate homeostasis[J]. Biochem Pharmacol,2002,63(2) :105 - 115.
10Sternberg CN, Vogelzang NJ. Gemcitabine, paclitaxd, pemetrexed and other newer agents inurothelial and kidney cancers[J]. Hematol Oncol,2003,46(2) :105 - 115.
